Lamotrigine Tablet
Product Images NDC 84677-034

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Lamotrigine (NDC 84677-034). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

84677-031-30lb (Lamotrigine ODT 25mg 30ct.jpg)

LAMOTRIGINE 25 mg orally disintegrating tablets, USP, label from Golden State Medical Supply, Inc. The label shows a bottle with 30 tablets, including a caution to verify the product dispensed and pharmacist dispensing instructions. It highlights the dosage strength (25 mg) and provides storage instructions, safety warnings, and marketing information for GSMS, Incorporated, Camarillo, CA.*

FDA Label Image

84677-032-30lb (Lamotrigine ODT 50mg 30ct.jpg)

Label for LAMOTRIGINE Orally Disintegrating Tablets USP 50 mg, with a package containing 30 tablets for oral use. The label shows the active ingredient strength, NDC code 84677-032-30, caution to verify product dispensed, storage instructions, and marketer information: GSMS, Incorporated, Camarillo, CA. The label also includes a barcode and QR code.*

FDA Label Image

84677-033-30lb (Lamotrigine ODT 100mg 30ct.jpg)

LAMOTRIGINE Orally Disintegrating Tablets USP 100 mg bottle label by Golden State Medical Supply, Inc. The label states the package contains 30 tablets and notes the product is Rx only. Safety instructions include verifying product dispensed and handling details such as child-resistance, storage conditions, and sealing instructions. The label also provides usage cautions and marketer contact information.*

FDA Label Image

84677-034-30lb (Lamotrigine ODT 200mg 30ct.jpg)

Label for lamotrigine orally disintegrating tablets, USP, 200 mg strength. The label indicates a package of 30 tablets, prescription only, distributed by GSMS, Incorporated, Camarillo, CA. It includes cautionary instructions to verify the product dispensed, dispensing guidelines, storage conditions, and child-resistant packaging information.*

FDA Label Image

Chemical Structure (Lamotrigine 01)

Chemical structure of lamotrigine, showing a dichlorophenyl group attached to a triazine ring with amino substitutions.*

FDA Label Image

Figure 1 (Lamotrigine 02)

A Kaplan-Meier failure probability curve comparing Lamotrigine OD Tablets with placebo over a 100-week period. The x-axis represents weeks and the y-axis shows failure probability as a percentage. The graph includes censoring marks and illustrates survival trends for both groups.*

FDA Label Image

Figure 2 (Lamotrigine 03)

A line graph comparing failure probability percentages over weeks between Placebo and Lamotrigine OD Tablets. The x-axis represents time in weeks (0 to 80), and the y-axis represents failure probability percentage (0 to 100%). Both groups show increasing failure probability over time, with Placebo generally higher. The graph includes censored data points marked with plus signs.*

FDA Label Image

Pg 1 (Pg 1)

Medication guide for Lamotrigine orally disintegrating tablets, USP, providing safety information about serious skin rash risks, other serious reactions such as liver problems, and conditions requiring immediate healthcare provider contact. It includes warnings for patients with heart problems and lists symptoms that warrant urgent medical attention.*

FDA Label Image

Pg 2 (Pg 2)

This text panel details warnings related to lamotrigine orally disintegrating tablets, including risks of suicidal thoughts or actions and aseptic meningitis. It outlines symptoms to watch for, advises contacting healthcare providers promptly, and emphasizes not stopping the medication without medical advice. Safety monitoring recommendations and symptom descriptions are included.*

FDA Label Image

Pg 3 (Pg 3)

This text panel provides detailed descriptions and images of lamotrigine orally disintegrating tablets in strengths of 25 mg, 50 mg, 100 mg, and 200 mg, showing differences in shape, color, and debossed markings. It includes warnings about medication errors and summarizes key usage information about the tablets, including their treatment applications and safety considerations.*

FDA Label Image

Pg 4 (Pg 4)

Text panel providing detailed patient information about lamotrigine orally disintegrating tablets. It includes guidance on health conditions to discuss with a healthcare provider, instructions for use, precautions to avoid while taking the tablets, the importance of medication management, and warnings about potential side effects and drug interactions.*

FDA Label Image

Pg 5 (Pg 5)

Text panel providing medication guide information for lamotrigine orally disintegrating tablets, including common side effects, storage instructions, general usage information, warnings about drug screening tests, and a list of active and inactive ingredients. Manufacturer and distributor details are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.